LumiraDx Investor Presentation Deck

Current POC Solutions Have Major Limitations The traditional approach to POC test development has limited scalability and has resulted in ineffective, inefficient and costly solutions X Poor clinical performance in areas of high clinical need X High cost of total ownership X Limited test menu lumiraDx™ 85 Coagulation Respiratory Molecular Copyright © 2023 LumiraDx Ltd. All Rights Reserved, Worldwide. BDS O Respiratory Immunoassay 20x Jo Diabetes, Cardiovascular Diabetes, Inflammation A Cardiac, Blood gas, Metabolic 7

View entire presentation